Swiss National Bank - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$7,480,272
-18.1%
164,800
+1.3%
0.01%0.0%
Q2 2023$9,133,978
+25.8%
162,700
+1.4%
0.01%
+20.0%
Q1 2023$7,259,415
-0.2%
160,500
-10.3%
0.01%0.0%
Q4 2022$7,276,350
-36.2%
179,000
+2.6%
0.01%
-37.5%
Q3 2022$11,404,000
+8.6%
174,500
+1.0%
0.01%
+14.3%
Q2 2022$10,501,000
+15.6%
172,800
+19.4%
0.01%
+40.0%
Q1 2022$9,083,000
-10.6%
144,700
+8.0%
0.01%
-16.7%
Q4 2021$10,155,000
-32.3%
134,0000.0%0.01%
-40.0%
Q3 2021$14,999,000
-30.3%
134,000
+0.8%
0.01%
-23.1%
Q2 2021$21,531,000
+30.8%
133,000
-1.6%
0.01%
+18.2%
Q1 2021$16,462,000
-9.6%
135,100
+13.5%
0.01%
-15.4%
Q4 2020$18,220,000
+87.3%
119,000
+2.3%
0.01%
+62.5%
Q3 2020$9,727,000
+49.9%
116,300
+31.7%
0.01%
+60.0%
Q2 2020$6,489,000
+162.4%
88,300
+51.5%
0.01%
+66.7%
Q1 2020$2,473,000
-22.4%
58,300
+11.5%
0.00%0.0%
Q4 2019$3,185,000
+57.0%
52,300
+5.7%
0.00%
+50.0%
Q3 2019$2,029,000
-11.4%
49,500
+1.9%
0.00%0.0%
Q2 2019$2,289,000
+69.6%
48,600
+28.6%
0.00%
+100.0%
Q1 2019$1,350,000
+39.8%
37,800
+11.8%
0.00%0.0%
Q4 2018$966,000
-35.6%
33,8000.0%0.00%
-50.0%
Q3 2018$1,499,000
-22.2%
33,800
+3.0%
0.00%0.0%
Q2 2018$1,927,00032,8000.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q3 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$27,989,04633.20%
Gilfoyle Management LLC 100$4,84215.90%
NEA Management Company, LLC 1,587,854$89,142,1246.80%
ARK Investment Management 7,338,447$411,980,3942.73%
Nikko Asset Management Americas, Inc. 3,533,357$198,327,3282.09%
Del-Sette Capital Management, LLC 33,661$1,889,7291.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Merlin Capital, Inc 8,802$494,1441.67%
Green Alpha Advisors, LLC 34,373$1,929,7001.27%
View complete list of CRISPR THERAPEUTICS AG shareholders